nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—ABCB1—Methylprednisolone—psoriatic arthritis	0.0991	0.157	CbGbCtD
Vinorelbine—ABCB1—Betamethasone—psoriatic arthritis	0.0644	0.102	CbGbCtD
Vinorelbine—ABCB1—Prednisolone—psoriatic arthritis	0.0636	0.101	CbGbCtD
Vinorelbine—ABCB1—Prednisone—psoriatic arthritis	0.06	0.0954	CbGbCtD
Vinorelbine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0594	0.0943	CbGbCtD
Vinorelbine—CYP3A4—Triamcinolone—psoriatic arthritis	0.045	0.0715	CbGbCtD
Vinorelbine—CYP3A4—Betamethasone—psoriatic arthritis	0.0386	0.0613	CbGbCtD
Vinorelbine—CYP3A4—Prednisolone—psoriatic arthritis	0.0381	0.0605	CbGbCtD
Vinorelbine—ABCB1—Dexamethasone—psoriatic arthritis	0.0375	0.0595	CbGbCtD
Vinorelbine—CYP3A4—Prednisone—psoriatic arthritis	0.036	0.0571	CbGbCtD
Vinorelbine—CYP2D6—Dexamethasone—psoriatic arthritis	0.0353	0.0561	CbGbCtD
Vinorelbine—ABCB1—Methotrexate—psoriatic arthritis	0.0301	0.0478	CbGbCtD
Vinorelbine—CYP3A4—Dexamethasone—psoriatic arthritis	0.0224	0.0357	CbGbCtD
Vinorelbine—Angiopathy—Betamethasone—psoriatic arthritis	0.000665	0.00179	CcSEcCtD
Vinorelbine—Hypertension—Prednisolone—psoriatic arthritis	0.000661	0.00178	CcSEcCtD
Vinorelbine—Arrhythmia—Betamethasone—psoriatic arthritis	0.000655	0.00177	CcSEcCtD
Vinorelbine—Arrhythmia—Dexamethasone—psoriatic arthritis	0.000655	0.00177	CcSEcCtD
Vinorelbine—Pancreatitis—Methotrexate—psoriatic arthritis	0.000654	0.00176	CcSEcCtD
Vinorelbine—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000653	0.00176	CcSEcCtD
Vinorelbine—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000651	0.00176	CcSEcCtD
Vinorelbine—Alopecia—Dexamethasone—psoriatic arthritis	0.000648	0.00175	CcSEcCtD
Vinorelbine—Alopecia—Betamethasone—psoriatic arthritis	0.000648	0.00175	CcSEcCtD
Vinorelbine—Discomfort—Prednisolone—psoriatic arthritis	0.000644	0.00174	CcSEcCtD
Vinorelbine—Angioedema—Triamcinolone—psoriatic arthritis	0.000643	0.00173	CcSEcCtD
Vinorelbine—Angioedema—Methylprednisolone—psoriatic arthritis	0.000641	0.00173	CcSEcCtD
Vinorelbine—Erythema—Dexamethasone—psoriatic arthritis	0.000638	0.00172	CcSEcCtD
Vinorelbine—Erythema—Betamethasone—psoriatic arthritis	0.000638	0.00172	CcSEcCtD
Vinorelbine—Malaise—Triamcinolone—psoriatic arthritis	0.000634	0.00171	CcSEcCtD
Vinorelbine—Pancytopenia—Methotrexate—psoriatic arthritis	0.000633	0.00171	CcSEcCtD
Vinorelbine—Malaise—Methylprednisolone—psoriatic arthritis	0.000633	0.00171	CcSEcCtD
Vinorelbine—Vertigo—Triamcinolone—psoriatic arthritis	0.000632	0.00171	CcSEcCtD
Vinorelbine—Vertigo—Methylprednisolone—psoriatic arthritis	0.000631	0.0017	CcSEcCtD
Vinorelbine—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000628	0.00169	CcSEcCtD
Vinorelbine—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000624	0.00168	CcSEcCtD
Vinorelbine—Neutropenia—Methotrexate—psoriatic arthritis	0.000624	0.00168	CcSEcCtD
Vinorelbine—Cough—Triamcinolone—psoriatic arthritis	0.000614	0.00166	CcSEcCtD
Vinorelbine—Tachycardia—Prednisolone—psoriatic arthritis	0.000609	0.00164	CcSEcCtD
Vinorelbine—Hypertension—Triamcinolone—psoriatic arthritis	0.000607	0.00164	CcSEcCtD
Vinorelbine—Hypertension—Methylprednisolone—psoriatic arthritis	0.000606	0.00164	CcSEcCtD
Vinorelbine—Myalgia—Triamcinolone—psoriatic arthritis	0.000599	0.00162	CcSEcCtD
Vinorelbine—Pneumonia—Methotrexate—psoriatic arthritis	0.000598	0.00161	CcSEcCtD
Vinorelbine—Myalgia—Methylprednisolone—psoriatic arthritis	0.000598	0.00161	CcSEcCtD
Vinorelbine—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000598	0.00161	CcSEcCtD
Vinorelbine—Infestation NOS—Methotrexate—psoriatic arthritis	0.000595	0.0016	CcSEcCtD
Vinorelbine—Infestation—Methotrexate—psoriatic arthritis	0.000595	0.0016	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000594	0.0016	CcSEcCtD
Vinorelbine—Flushing—Prednisone—psoriatic arthritis	0.000593	0.0016	CcSEcCtD
Vinorelbine—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000592	0.0016	CcSEcCtD
Vinorelbine—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000592	0.0016	CcSEcCtD
Vinorelbine—Discomfort—Triamcinolone—psoriatic arthritis	0.000592	0.0016	CcSEcCtD
Vinorelbine—Discomfort—Methylprednisolone—psoriatic arthritis	0.00059	0.00159	CcSEcCtD
Vinorelbine—Angioedema—Betamethasone—psoriatic arthritis	0.000583	0.00157	CcSEcCtD
Vinorelbine—Angioedema—Dexamethasone—psoriatic arthritis	0.000583	0.00157	CcSEcCtD
Vinorelbine—Stomatitis—Methotrexate—psoriatic arthritis	0.00058	0.00156	CcSEcCtD
Vinorelbine—Angiopathy—Prednisone—psoriatic arthritis	0.000579	0.00156	CcSEcCtD
Vinorelbine—Immune system disorder—Prednisone—psoriatic arthritis	0.000577	0.00156	CcSEcCtD
Vinorelbine—Malaise—Betamethasone—psoriatic arthritis	0.000576	0.00155	CcSEcCtD
Vinorelbine—Malaise—Dexamethasone—psoriatic arthritis	0.000576	0.00155	CcSEcCtD
Vinorelbine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000574	0.00155	CcSEcCtD
Vinorelbine—Vertigo—Betamethasone—psoriatic arthritis	0.000574	0.00155	CcSEcCtD
Vinorelbine—Vertigo—Dexamethasone—psoriatic arthritis	0.000574	0.00155	CcSEcCtD
Vinorelbine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000573	0.00155	CcSEcCtD
Vinorelbine—Arrhythmia—Prednisone—psoriatic arthritis	0.00057	0.00154	CcSEcCtD
Vinorelbine—Infection—Triamcinolone—psoriatic arthritis	0.00057	0.00154	CcSEcCtD
Vinorelbine—Infection—Methylprednisolone—psoriatic arthritis	0.000569	0.00154	CcSEcCtD
Vinorelbine—Alopecia—Prednisone—psoriatic arthritis	0.000564	0.00152	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000562	0.00152	CcSEcCtD
Vinorelbine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000562	0.00152	CcSEcCtD
Vinorelbine—Paraesthesia—Prednisolone—psoriatic arthritis	0.000561	0.00151	CcSEcCtD
Vinorelbine—Tachycardia—Triamcinolone—psoriatic arthritis	0.00056	0.00151	CcSEcCtD
Vinorelbine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000559	0.00151	CcSEcCtD
Vinorelbine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000556	0.0015	CcSEcCtD
Vinorelbine—Erythema—Prednisone—psoriatic arthritis	0.000556	0.0015	CcSEcCtD
Vinorelbine—Malnutrition—Prednisone—psoriatic arthritis	0.000556	0.0015	CcSEcCtD
Vinorelbine—Agranulocytosis—Methotrexate—psoriatic arthritis	0.000555	0.0015	CcSEcCtD
Vinorelbine—Hypertension—Betamethasone—psoriatic arthritis	0.000551	0.00149	CcSEcCtD
Vinorelbine—Hypertension—Dexamethasone—psoriatic arthritis	0.000551	0.00149	CcSEcCtD
Vinorelbine—Myalgia—Dexamethasone—psoriatic arthritis	0.000543	0.00147	CcSEcCtD
Vinorelbine—Myalgia—Betamethasone—psoriatic arthritis	0.000543	0.00147	CcSEcCtD
Vinorelbine—Discomfort—Betamethasone—psoriatic arthritis	0.000537	0.00145	CcSEcCtD
Vinorelbine—Discomfort—Dexamethasone—psoriatic arthritis	0.000537	0.00145	CcSEcCtD
Vinorelbine—Hypotension—Methylprednisolone—psoriatic arthritis	0.000535	0.00144	CcSEcCtD
Vinorelbine—Pain—Prednisolone—psoriatic arthritis	0.000534	0.00144	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000523	0.00141	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000522	0.00141	CcSEcCtD
Vinorelbine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000521	0.00141	CcSEcCtD
Vinorelbine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000521	0.00141	CcSEcCtD
Vinorelbine—Infection—Betamethasone—psoriatic arthritis	0.000518	0.0014	CcSEcCtD
Vinorelbine—Infection—Dexamethasone—psoriatic arthritis	0.000518	0.0014	CcSEcCtD
Vinorelbine—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000516	0.00139	CcSEcCtD
Vinorelbine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000516	0.00139	CcSEcCtD
Vinorelbine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000515	0.00139	CcSEcCtD
Vinorelbine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000514	0.00139	CcSEcCtD
Vinorelbine—Anaemia—Prednisone—psoriatic arthritis	0.000514	0.00139	CcSEcCtD
Vinorelbine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000512	0.00138	CcSEcCtD
Vinorelbine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000511	0.00138	CcSEcCtD
Vinorelbine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000511	0.00138	CcSEcCtD
Vinorelbine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00051	0.00138	CcSEcCtD
Vinorelbine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00051	0.00138	CcSEcCtD
Vinorelbine—Tachycardia—Dexamethasone—psoriatic arthritis	0.000508	0.00137	CcSEcCtD
Vinorelbine—Tachycardia—Betamethasone—psoriatic arthritis	0.000508	0.00137	CcSEcCtD
Vinorelbine—Angioedema—Prednisone—psoriatic arthritis	0.000508	0.00137	CcSEcCtD
Vinorelbine—Malaise—Prednisone—psoriatic arthritis	0.000501	0.00135	CcSEcCtD
Vinorelbine—Vertigo—Prednisone—psoriatic arthritis	0.000499	0.00135	CcSEcCtD
Vinorelbine—Anorexia—Dexamethasone—psoriatic arthritis	0.000497	0.00134	CcSEcCtD
Vinorelbine—Anorexia—Betamethasone—psoriatic arthritis	0.000497	0.00134	CcSEcCtD
Vinorelbine—Urticaria—Prednisolone—psoriatic arthritis	0.000496	0.00134	CcSEcCtD
Vinorelbine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000495	0.00134	CcSEcCtD
Vinorelbine—Fatigue—Triamcinolone—psoriatic arthritis	0.000495	0.00134	CcSEcCtD
Vinorelbine—Fatigue—Methylprednisolone—psoriatic arthritis	0.000494	0.00133	CcSEcCtD
Vinorelbine—Pain—Triamcinolone—psoriatic arthritis	0.000491	0.00132	CcSEcCtD
Vinorelbine—Hypotension—Betamethasone—psoriatic arthritis	0.000487	0.00131	CcSEcCtD
Vinorelbine—Hypotension—Dexamethasone—psoriatic arthritis	0.000487	0.00131	CcSEcCtD
Vinorelbine—Angiopathy—Methotrexate—psoriatic arthritis	0.000484	0.00131	CcSEcCtD
Vinorelbine—Immune system disorder—Methotrexate—psoriatic arthritis	0.000482	0.0013	CcSEcCtD
Vinorelbine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000481	0.0013	CcSEcCtD
Vinorelbine—Hypertension—Prednisone—psoriatic arthritis	0.00048	0.00129	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000475	0.00128	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000475	0.00128	CcSEcCtD
Vinorelbine—Arthralgia—Prednisone—psoriatic arthritis	0.000473	0.00128	CcSEcCtD
Vinorelbine—Myalgia—Prednisone—psoriatic arthritis	0.000473	0.00128	CcSEcCtD
Vinorelbine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000473	0.00128	CcSEcCtD
Vinorelbine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000472	0.00127	CcSEcCtD
Vinorelbine—Alopecia—Methotrexate—psoriatic arthritis	0.000472	0.00127	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00047	0.00127	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000468	0.00126	CcSEcCtD
Vinorelbine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000468	0.00126	CcSEcCtD
Vinorelbine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000468	0.00126	CcSEcCtD
Vinorelbine—Discomfort—Prednisone—psoriatic arthritis	0.000468	0.00126	CcSEcCtD
Vinorelbine—Malnutrition—Methotrexate—psoriatic arthritis	0.000465	0.00125	CcSEcCtD
Vinorelbine—Erythema—Methotrexate—psoriatic arthritis	0.000465	0.00125	CcSEcCtD
Vinorelbine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00046	0.00124	CcSEcCtD
Vinorelbine—Urticaria—Triamcinolone—psoriatic arthritis	0.000456	0.00123	CcSEcCtD
Vinorelbine—Urticaria—Methylprednisolone—psoriatic arthritis	0.000455	0.00123	CcSEcCtD
Vinorelbine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000454	0.00122	CcSEcCtD
Vinorelbine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000454	0.00122	CcSEcCtD
Vinorelbine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000453	0.00122	CcSEcCtD
Vinorelbine—Decreased appetite—Betamethasone—psoriatic arthritis	0.000453	0.00122	CcSEcCtD
Vinorelbine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000453	0.00122	CcSEcCtD
Vinorelbine—Infection—Prednisone—psoriatic arthritis	0.000451	0.00122	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00045	0.00121	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00045	0.00121	CcSEcCtD
Vinorelbine—Back pain—Methotrexate—psoriatic arthritis	0.000449	0.00121	CcSEcCtD
Vinorelbine—Fatigue—Betamethasone—psoriatic arthritis	0.000449	0.00121	CcSEcCtD
Vinorelbine—Fatigue—Dexamethasone—psoriatic arthritis	0.000449	0.00121	CcSEcCtD
Vinorelbine—Pain—Betamethasone—psoriatic arthritis	0.000446	0.0012	CcSEcCtD
Vinorelbine—Pain—Dexamethasone—psoriatic arthritis	0.000446	0.0012	CcSEcCtD
Vinorelbine—Nervous system disorder—Prednisone—psoriatic arthritis	0.000445	0.0012	CcSEcCtD
Vinorelbine—Tachycardia—Prednisone—psoriatic arthritis	0.000443	0.00119	CcSEcCtD
Vinorelbine—Skin disorder—Prednisone—psoriatic arthritis	0.000441	0.00119	CcSEcCtD
Vinorelbine—Anorexia—Prednisone—psoriatic arthritis	0.000432	0.00117	CcSEcCtD
Vinorelbine—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000431	0.00116	CcSEcCtD
Vinorelbine—Anaemia—Methotrexate—psoriatic arthritis	0.000429	0.00116	CcSEcCtD
Vinorelbine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000429	0.00116	CcSEcCtD
Vinorelbine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000429	0.00116	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000426	0.00115	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000426	0.00115	CcSEcCtD
Vinorelbine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000423	0.00114	CcSEcCtD
Vinorelbine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000422	0.00114	CcSEcCtD
Vinorelbine—Malaise—Methotrexate—psoriatic arthritis	0.000419	0.00113	CcSEcCtD
Vinorelbine—Vertigo—Methotrexate—psoriatic arthritis	0.000417	0.00113	CcSEcCtD
Vinorelbine—Leukopenia—Methotrexate—psoriatic arthritis	0.000416	0.00112	CcSEcCtD
Vinorelbine—Urticaria—Betamethasone—psoriatic arthritis	0.000414	0.00112	CcSEcCtD
Vinorelbine—Urticaria—Dexamethasone—psoriatic arthritis	0.000414	0.00112	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000413	0.00112	CcSEcCtD
Vinorelbine—Dizziness—Prednisolone—psoriatic arthritis	0.000413	0.00111	CcSEcCtD
Vinorelbine—Asthenia—Triamcinolone—psoriatic arthritis	0.000412	0.00111	CcSEcCtD
Vinorelbine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000412	0.00111	CcSEcCtD
Vinorelbine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000412	0.00111	CcSEcCtD
Vinorelbine—Body temperature increased—Betamethasone—psoriatic arthritis	0.000412	0.00111	CcSEcCtD
Vinorelbine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000412	0.00111	CcSEcCtD
Vinorelbine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000411	0.00111	CcSEcCtD
Vinorelbine—Paraesthesia—Prednisone—psoriatic arthritis	0.000407	0.0011	CcSEcCtD
Vinorelbine—Pruritus—Triamcinolone—psoriatic arthritis	0.000406	0.0011	CcSEcCtD
Vinorelbine—Cough—Methotrexate—psoriatic arthritis	0.000405	0.00109	CcSEcCtD
Vinorelbine—Pruritus—Methylprednisolone—psoriatic arthritis	0.000405	0.00109	CcSEcCtD
Vinorelbine—Myalgia—Methotrexate—psoriatic arthritis	0.000396	0.00107	CcSEcCtD
Vinorelbine—Arthralgia—Methotrexate—psoriatic arthritis	0.000396	0.00107	CcSEcCtD
Vinorelbine—Chest pain—Methotrexate—psoriatic arthritis	0.000396	0.00107	CcSEcCtD
Vinorelbine—Decreased appetite—Prednisone—psoriatic arthritis	0.000394	0.00106	CcSEcCtD
Vinorelbine—Rash—Prednisolone—psoriatic arthritis	0.000394	0.00106	CcSEcCtD
Vinorelbine—Dermatitis—Prednisolone—psoriatic arthritis	0.000393	0.00106	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000393	0.00106	CcSEcCtD
Vinorelbine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000392	0.00106	CcSEcCtD
Vinorelbine—Fatigue—Prednisone—psoriatic arthritis	0.000391	0.00106	CcSEcCtD
Vinorelbine—Headache—Prednisolone—psoriatic arthritis	0.000391	0.00106	CcSEcCtD
Vinorelbine—Discomfort—Methotrexate—psoriatic arthritis	0.000391	0.00105	CcSEcCtD
Vinorelbine—Constipation—Prednisone—psoriatic arthritis	0.000388	0.00105	CcSEcCtD
Vinorelbine—Dizziness—Triamcinolone—psoriatic arthritis	0.00038	0.00102	CcSEcCtD
Vinorelbine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000379	0.00102	CcSEcCtD
Vinorelbine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000379	0.00102	CcSEcCtD
Vinorelbine—Infection—Methotrexate—psoriatic arthritis	0.000377	0.00102	CcSEcCtD
Vinorelbine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000374	0.00101	CcSEcCtD
Vinorelbine—Asthenia—Dexamethasone—psoriatic arthritis	0.000374	0.00101	CcSEcCtD
Vinorelbine—Asthenia—Betamethasone—psoriatic arthritis	0.000374	0.00101	CcSEcCtD
Vinorelbine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000372	0.001	CcSEcCtD
Vinorelbine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000371	0.001	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000371	0.001	CcSEcCtD
Vinorelbine—Nausea—Prednisolone—psoriatic arthritis	0.000371	0.001	CcSEcCtD
Vinorelbine—Pruritus—Dexamethasone—psoriatic arthritis	0.000369	0.000994	CcSEcCtD
Vinorelbine—Pruritus—Betamethasone—psoriatic arthritis	0.000369	0.000994	CcSEcCtD
Vinorelbine—Skin disorder—Methotrexate—psoriatic arthritis	0.000368	0.000994	CcSEcCtD
Vinorelbine—Vomiting—Triamcinolone—psoriatic arthritis	0.000365	0.000985	CcSEcCtD
Vinorelbine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000364	0.000983	CcSEcCtD
Vinorelbine—Rash—Triamcinolone—psoriatic arthritis	0.000362	0.000977	CcSEcCtD
Vinorelbine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000362	0.000976	CcSEcCtD
Vinorelbine—Anorexia—Methotrexate—psoriatic arthritis	0.000361	0.000975	CcSEcCtD
Vinorelbine—Rash—Methylprednisolone—psoriatic arthritis	0.000361	0.000975	CcSEcCtD
Vinorelbine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000361	0.000974	CcSEcCtD
Vinorelbine—Urticaria—Prednisone—psoriatic arthritis	0.00036	0.000972	CcSEcCtD
Vinorelbine—Headache—Triamcinolone—psoriatic arthritis	0.00036	0.00097	CcSEcCtD
Vinorelbine—Headache—Methylprednisolone—psoriatic arthritis	0.000359	0.000968	CcSEcCtD
Vinorelbine—Body temperature increased—Prednisone—psoriatic arthritis	0.000359	0.000968	CcSEcCtD
Vinorelbine—Abdominal pain—Prednisone—psoriatic arthritis	0.000359	0.000968	CcSEcCtD
Vinorelbine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000356	0.000962	CcSEcCtD
Vinorelbine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000356	0.000962	CcSEcCtD
Vinorelbine—Hypotension—Methotrexate—psoriatic arthritis	0.000354	0.000956	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000345	0.000932	CcSEcCtD
Vinorelbine—Dizziness—Betamethasone—psoriatic arthritis	0.000345	0.000929	CcSEcCtD
Vinorelbine—Dizziness—Dexamethasone—psoriatic arthritis	0.000345	0.000929	CcSEcCtD
Vinorelbine—Nausea—Triamcinolone—psoriatic arthritis	0.000341	0.00092	CcSEcCtD
Vinorelbine—Paraesthesia—Methotrexate—psoriatic arthritis	0.00034	0.000919	CcSEcCtD
Vinorelbine—Nausea—Methylprednisolone—psoriatic arthritis	0.00034	0.000918	CcSEcCtD
Vinorelbine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000338	0.000912	CcSEcCtD
Vinorelbine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000334	0.000902	CcSEcCtD
Vinorelbine—Vomiting—Betamethasone—psoriatic arthritis	0.000331	0.000894	CcSEcCtD
Vinorelbine—Vomiting—Dexamethasone—psoriatic arthritis	0.000331	0.000894	CcSEcCtD
Vinorelbine—Decreased appetite—Methotrexate—psoriatic arthritis	0.00033	0.000889	CcSEcCtD
Vinorelbine—Rash—Betamethasone—psoriatic arthritis	0.000328	0.000886	CcSEcCtD
Vinorelbine—Rash—Dexamethasone—psoriatic arthritis	0.000328	0.000886	CcSEcCtD
Vinorelbine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000328	0.000885	CcSEcCtD
Vinorelbine—Dermatitis—Betamethasone—psoriatic arthritis	0.000328	0.000885	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000327	0.000883	CcSEcCtD
Vinorelbine—Fatigue—Methotrexate—psoriatic arthritis	0.000327	0.000882	CcSEcCtD
Vinorelbine—Headache—Betamethasone—psoriatic arthritis	0.000326	0.000881	CcSEcCtD
Vinorelbine—Headache—Dexamethasone—psoriatic arthritis	0.000326	0.000881	CcSEcCtD
Vinorelbine—Asthenia—Prednisone—psoriatic arthritis	0.000326	0.000878	CcSEcCtD
Vinorelbine—Pain—Methotrexate—psoriatic arthritis	0.000324	0.000875	CcSEcCtD
Vinorelbine—Pruritus—Prednisone—psoriatic arthritis	0.000321	0.000866	CcSEcCtD
Vinorelbine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000312	0.000843	CcSEcCtD
Vinorelbine—Diarrhoea—Prednisone—psoriatic arthritis	0.00031	0.000838	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.00031	0.000837	CcSEcCtD
Vinorelbine—Nausea—Betamethasone—psoriatic arthritis	0.000309	0.000835	CcSEcCtD
Vinorelbine—Nausea—Dexamethasone—psoriatic arthritis	0.000309	0.000835	CcSEcCtD
Vinorelbine—Urticaria—Methotrexate—psoriatic arthritis	0.000301	0.000813	CcSEcCtD
Vinorelbine—Dizziness—Prednisone—psoriatic arthritis	0.0003	0.000809	CcSEcCtD
Vinorelbine—Abdominal pain—Methotrexate—psoriatic arthritis	0.0003	0.000809	CcSEcCtD
Vinorelbine—Body temperature increased—Methotrexate—psoriatic arthritis	0.0003	0.000809	CcSEcCtD
Vinorelbine—Vomiting—Prednisone—psoriatic arthritis	0.000288	0.000778	CcSEcCtD
Vinorelbine—Rash—Prednisone—psoriatic arthritis	0.000286	0.000772	CcSEcCtD
Vinorelbine—Dermatitis—Prednisone—psoriatic arthritis	0.000286	0.000771	CcSEcCtD
Vinorelbine—Headache—Prednisone—psoriatic arthritis	0.000284	0.000767	CcSEcCtD
Vinorelbine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000279	0.000754	CcSEcCtD
Vinorelbine—Asthenia—Methotrexate—psoriatic arthritis	0.000272	0.000734	CcSEcCtD
Vinorelbine—Nausea—Prednisone—psoriatic arthritis	0.000269	0.000727	CcSEcCtD
Vinorelbine—Pruritus—Methotrexate—psoriatic arthritis	0.000268	0.000724	CcSEcCtD
Vinorelbine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000259	0.0007	CcSEcCtD
Vinorelbine—Dizziness—Methotrexate—psoriatic arthritis	0.000251	0.000676	CcSEcCtD
Vinorelbine—Vomiting—Methotrexate—psoriatic arthritis	0.000241	0.00065	CcSEcCtD
Vinorelbine—Rash—Methotrexate—psoriatic arthritis	0.000239	0.000645	CcSEcCtD
Vinorelbine—Dermatitis—Methotrexate—psoriatic arthritis	0.000239	0.000644	CcSEcCtD
Vinorelbine—Headache—Methotrexate—psoriatic arthritis	0.000238	0.000641	CcSEcCtD
Vinorelbine—Nausea—Methotrexate—psoriatic arthritis	0.000225	0.000608	CcSEcCtD
